Spruce Biosciences (SPRB) Stock: Buy, Sell, or Hold?
SPRB - Spruce Biosciences, Inc. Common Stock
$45.71
0.94 (2.10%)
▲
5d:
-6.18%
30d:
-23.4%
90d:
-11.84%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 09, 2026
Get Alerted When SPRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SPRB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SPRB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$86.44
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$53.67
14.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SPRB is currently trading at $45.71, which is considered oversold relative to its 30-day fair value range of $48.92 to $58.94. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.2) compared to its historical average (12.4). Remarkably, the market is currently pricing in an annual earnings decline of 9.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SPRB is showing sideways momentum. Immediate support is located at $44.12, while resistance sits at $55.05.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $148.00 (+223.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SPRB is showing sideways momentum. Immediate support is located at $44.12, while resistance sits at $55.05.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $148.00 (+223.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$48.92 -
$58.94
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 223.8% below Wall St target ($148.00)
- NEUTRAL: Bottoming setup forming (53/100) — watch for confirmation
- CAUTION: 5-day price weakness (-6.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$48.92 -
$58.94
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$44.13
Resistance Level
$55.06
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.19
Wall Street Target
$148.00
(+223.8%)
Revenue Growth (YoY)
-75.9%
Valuation Discount vs History
-9.5% cheaper
PE vs Historical
9.2 vs 12.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.5%
(market-implied from PE analysis)
1-Year Target
$41.37
(-10%)
2-Year Target
$37.44
(-18%)
3-Year Target
$33.88
(-26%)
3-Yr Target (if PE normalizes)
(PE: 9→12)
$45.73
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.2 to 12.4
Stabilization Target:
$61.69
(+35.0%)
PE Expansion Potential:
+35.0%
Share & Embed Analysis
Last updated: October 04, 2026 3:59 AM ET
Data refreshes hourly during market hours. Next update: 4:59 AM
Data refreshes hourly during market hours. Next update: 4:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SPRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$371 | 49 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 56 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$570 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$310 | 66 BUY |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$63 | 60 BUY |
